FDA Inspection 1060488 — Takeda GmbH
The FDA completed an inspection of Takeda GmbH on Mar 27, 2018 in Singen (Hohentwiel). The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 27, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Singen (Hohentwiel) (Germany)